Popular on s4story
- NIUFO Positions Platform for European Market Entry with MiCA-Aligned Infrastructure Development - 207
- 3Ei Recruiter Defines the Product Category for Empathy-driven AI - 200
- New Book Illuminates Notre Dame's Enduring Leadership Legacy - 167
- NYC Big Book Award® announces the 2025 Winners & Distinguished Favorites! - 163
- Community Redevelopment Inc.Signs Gold Production Contract with Mine CA Gold Ltd., - 158
- Newly-pubilshed: Bend or Break - From Empires to Algorithms - 158
- Angel's Awesome Books Launches Softcover "Positive Affirmation Journal for Kids" New Lower Price - 158
- Write Your Story Workshop 2025 - 158
- Who Will Win the 2025 Video Game of the Year? Bookmakers Review Shares Latest Odds - 156
- Boston Industrial Solutions Introduces Natron® UVPX Series UV-LED Curing Screen Printing Inks - 154
Similar on s4story
- Zero-Trust Architecture: NJTRX Addresses 60% of U.S. Investors' Custody Security Concerns
- Sub-Millisecond Trading Platform: HNZLLQ Introduces Unified Gateway for Philippine Digital Asset Traders
- $2.1B Theft Losses: Bitquore Launches 1M+ TPS Platform with 95% Offline Asset Protection for U.S. Traders
- America Anesthesia Partners Unveils New User-Friendly Website
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
- NKSCX Introduces Zero-Knowledge Proof of Solvency for U.S. Traders Amid $6.5 Billion Fraud Crisis
- New You Smile Dental Implant Center Expands Office
- Cold Storage and Proof-of-Reserves: BTXSGG Launches Institutional-Grade Asset Protection for Filipino Traders
- Why FIRE Enthusiasts Are Buying Businesses Instead of Just Saving Their Way to Freedom
MIRAmedtech and Bio-Infusions Join Forces in Bringing Aesthetic Medical Innovations to the USA
S For Story/10434157
SEMINOLE, Fla. & KARLSRUHE, Germany - s4story -- MIRAmedtech UG and Bio-Infusions USA announced today that they a have entered into an agreement, effective immediately, to provide a complete line of comprehensive aesthetic medical devices and topical treatments to cosmetic dermatologists, plastic surgeons, and aesthetic practitioners for the benefit of their patients throughout the United States.
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on S For Story
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on S For Story
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
The Companies have collaborated together in recent years to launch Bio-Infusion's Cleopatra™ branded Fractional Bio-Infusion System™, based on MIRAmedtech device technology and focused on international markets throughout Europe, the Pacific Rim and South America. This announcement comes as a result of their early success in those markets and the mutual desire to bring something truly innovative to the US market.
"There is an exciting opportunity to fill the demand for healthier and younger looking skin with a truly non-invasive treatment that takes advantage of the most current innovations in device technology and that also uses the most compelling new advances in topical bio-nutrient actives," said Serge Castro, Founder and Managing Director of MIRAmedtech UG. "That is what we are creating by combining MIRAmedtech device technologies and the encapsulated bio-active solution technologies that Bio-Infusions has created."
More on S For Story
- Bùng Nổ Ra Mắt, AALIVE Tung Gói Thưởng 68% và Dàn Game Thuần Việt Hấp Dẫn
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida
- Emanuel Rose Releases One Man, One Dog: Upland Bird Hunting with a Flushing Dog
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
All MIRApeel™ and Cleopatra™ branded devices are made in Germany by MIRAmedtech, the inventor of the phased non-invasive approach that combines transbrasion, fractional bio-infusion and LED light therapies with customized bio-nutrient topical delivery for an optimal skin-health response. The result is a dramatic improvement in skin tone and texture, supporting an overall improvement in skin health, without surgery.
"The strength of this treatment model is that it delights the patient with visible and continued improvements in the quality and appearance of their skin, at a lower cost per treatment relative to other treatment options currently available," said Paul Guilbaud, President of Bio-Infusions USA. "This combination technology is a superior compliment to their other core offerings, such as injectable fillers, IPL, or other energy-based technologies that work below the surface of the skin. This provides a superior ROI for the physician."
The Cleopatra™ and MIRApeel™ technologies are currently available throughout the USA direct from Bio-Infusions USA, Inc. and their authorized sales and distribution partners. For more information, go to www.CleopatraSkinHealth.com, write sales@bio-infusions.com or call 1-833-923-2889 ext. 2.
More on S For Story
- NKSCX Introduces Zero-Knowledge Proof of Solvency for U.S. Traders Amid $6.5 Billion Fraud Crisis
- New Oasis International Foundation Announces Strategic Partnership Network Across 15 Countries to Advance Community-Led Economic Development
- Some Music for Donald's Bad Day
- New You Smile Dental Implant Center Expands Office
- $8 Billion High-Margin National Gentlemen's Club Market Targeted by Acquisition Strategy Incorporating the Successful Peppermint Hippo™ Brand: $TRWD
ABOUT BIO-INFUSIONS USA, Inc. — Bio-Infusion develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from dermatologic conditions or desiring aesthetic improvement. The Company's leading products include the Cleopatra™ Fractional Bio-Infusion System™, a breakthrough device combining MIRAmedtech device technology with Bio-infusions® suite of potent active bio-nutrients targeting skin clarity, brightness, photo-damage and laxity for enhanced tissue delivery and improved patient outcomes. More information can be found at www.CleopatraSkinHealth.com
About MIRAmedtech U.G. — Engineered and designed to become a leader, MIRAmedtech is the inventor and manufacturer of MIRApeel™, the inventor of multi-phased non-invasive treatments that feature fractional bio-infusion, designed to make professional skin rejuvenation more effective and yet safer/more controlled. The resulting technology currently growing in popularity in over 15 countries worldwide, with a broad application in treating the range of skin tone and texture issues on the face and body. For more information, please visit www.MIRAmedtech.com
Source: Bio-Infusions USA
0 Comments
Latest on S For Story
- What If Help Could Come Before the Fall?
- Digi 995: Spookyverse — Unlocking the Multiverse of the Digiverse
- Fiction author re-imagines Acts of the Apostles with Female Apostles
- Combatting Commercial Clutter: Award-Winning Author Andrew Kooman Releases Gather for Advent
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Parker Stone Unleashes the Highly Anticipated Dark Romance, "The Reluctant Heir," Out Today
- Dirty Verse: Unhinged Humor in Rhyme Unleashed
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- Prince George's County MWA Hosts Historian Jean Burgess for Free Workshop
- Shafted: Serenity Acres – Volume II in the Drop-Dead Funny Thriller Series is Now Available
- Award-Winning Philadelphia Area Author, Tom Tracy, Launches Catalog of Diverse Kids Books to Counter Book Bans and DE&I Rollbacks
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana